Research Compound
Tirzepatide
by GYC
500mg total (10 vials)
Price per milligram
$0.44/mg
Total quantity
500mg
Payment
Bitcoin (BTC)
Shipping
Discreet US Domestic
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption.
Research Information
Overview
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It represents a novel approach in metabolic research by targeting two incretin pathways simultaneously.
Mechanism of Action
Tirzepatide activates both GIP and GLP-1 receptors, enhancing insulin secretion in a glucose-dependent manner, reducing glucagon levels, slowing gastric emptying, and promoting satiety through central nervous system effects.
Common Research Applications
- •Research on dual incretin receptor activation
- •Studies comparing single vs dual agonist efficacy
- •Metabolic syndrome research protocols
- •Investigation of body composition changes
Technical Details
Half-Life
Approximately 5 days, suitable for once-weekly research protocols.
Storage
Store lyophilized form at -20°C. After reconstitution, refrigerate at 2-8°C and use within 4 weeks.
Dosage Information
Research typically employs dose-escalation protocols. Refer to clinical trial publications for methodology.
Scientific References
- Jastreboff AM, et al. N Engl J Med. 2022;387(3):205-216
- Frias JP, et al. N Engl J Med. 2021;385(6):503-515